Antiplatelet and Anticoagulant Medications Significantly Increase the Risk of Postoperative Hematoma: Review of over 4500 Thyroid and Parathyroid Procedures.

ABSTRACT:

Purpose

Antiplatelet and/or anticoagulant medication use is common. Abstinence a week before surgery may still result in altered hemostasis. The study aim was to report on perioperative antiplatelet and anticoagulant use in thyroidectomy and parathyroidectomy patients, and to determine the association with postoperative hematoma (POH) rates.

Methods

Retrospective review of a prospective endocrine surgery database was performed. Procedure extent was defined as unilateral, bilateral, or extensive. Antiplatelets were categorized as none, 325 mg aspirin (ASA), <325 mg ASA, clopidogrel, or other. Anticoagulants were categorized as none, oral, or injectable.

Results

A total of 4514 patients were identified. POH developed in 22 patients (0.5 %). Rates were similar between ag

SUBMITTER: Oltmann SC 

PROVIDER: S-EPMC5120859 | biostudies-literature | 2016 Sep

REPOSITORIES: biostudies-literature